The Efficacy of Citalopram Treatment in Acute Stroke
Status:
Completed
Trial end date:
2016-12-19
Target enrollment:
Participant gender:
Summary
We wish to conduct a prospective, randomized, double blind, placebo controlled multi center
study of the combined neuroprotective and antithrombotic effects of SSRI treatment after
stroke.
Hypotheses:
SSRI treatment commenced in the acute phase of stroke (day 0-7) protects against new
thromboembolic events and leads to better rehabilitation. 600 stroke patients will be
randomized in a 1:1 ratio.
The treatment and follow up period is 6 months. During these 6 months there will be 2
clinical follow up visits, one telephone control and one visit to evaluate compliance
regarding medication.
Phase:
Phase 2
Details
Lead Sponsor:
University of Aarhus
Collaborators:
Danish Council for Independent Research The Danish Regions Medicine Foundation